Phase Ii trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study
Davis, R.B.; Van Echo, D.A.; Leone, L.A.; Henderson, E.S.
Cancer Treatment Reports 70(9): 1125-1126
1986
ISSN/ISBN: 0361-5960 PMID: 3742493 Document Number: 274091
Document emailed within 1 workday
Related Documents
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E. 1984: Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study Cancer Treatment Reports 68(10): 1305-1306Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
DeSimone, P.A.; Gams, R.; Bartolucci, A. 1986: Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(7): 929-930
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Eisenhauer, E.A.; Evans, W.K.; Raghavan, D.; Desmeules, M.J.; Murray, N.R.; Stuart-Harris, R.; Wilson, K.S. 1986: Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study Cancer Treatment Reports 70(8): 1029-1030
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Carpenter, J.T.; Raney, M.; Logan, T. 1986: Phase Ii evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(5): 679-680
Follézou, J.Y.; Palangie, T.; Feuilhade, F. 1987: Randomized trial comparing mitoxantrone with adriamycin in advanced breast cancer Presse Medicale 16(16): 765-768
Tominaga, T.; Nomura, Y.; Adachi, I.; Aoyama, H.; Nagao, K.; Mitsuyama, S.; Nakamura, Y.; Ogita, M.; Sano, M.; Takashima, S. 1994: Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 809-816
Small, E.J.; Dawson, N.A.; Kantoff, P.W.; Vogelzang, N.J. 1996: Cancer and Leukemia Group B trials for advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 28-31
Amrein, P.C.; Coleman, M.; Richards, F.; Bhardwaj, S.; Kennedy, B.J.; Haurani, F.I.; Frelick, R.W.; Pastmantier, M.W.; Herschkopf, R. 1984: Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase Ii study Cancer Treatment Reports 68(11): 1397-1398
Roach, M.; Cirrincione, C.; Budman, D.; Hayes, D.; Berry, D.; Younger, J.; Hart, R.; Henderson, I.C. 1997: Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541 Cancer Journal from Scientific American 3(2): 107-112
Ravry, M.J.; Moore, M.R.; Omura, G.A.; Esseese, I.; Bartolucci, A. 1985: Phase Ii evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial Cancer Treatment Reports 69(12): 1457-1458
Sugihara, K.; Auther, C.; Mori, S.; Nishihira, T.; Matsumoto, T.; Kawachi, S.; Ishikawa, M.; Takahashi, M.; Nakajima, T.; Kosaki, G. 1990: Early phase Ii study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2405-2413
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H. 1987: Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1313-1314
Wagener, D.J.; van Oosterom, A.T.; Mulder, J.H.; Somers, R.; Mouridsen, H.T.; Cortes Funes, H.; Thomas, D.; Sylvester, R. 1986: Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer Cancer Treatment Reports 70(5): 615-618